Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Copenhagen University Hospital at Herlev120 enrolled

Overview

To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Bladder Cancer

Interventions

Identifying genes methylated in urinePROCEDURE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer. Exclusion Criteria: * Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.

Locations (1)

Copenhagen University Hospital at Herlev

Herlev, Copenhagen, Denmark

RECRUITING

Central Contacts

Reza R Serizawa, MD

CONTACT

+45 44884787 rerase01@herlevhosp.kbhamt.dk

Jørgen H Andersen

CONTACT

johvan01@herlevhosp.kbhamt.dk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.